Tag: metastatic and advanced prostate cancer

FDA OKs First Oral Hormone Tx for Advanced Prostate Cancer

The US Food and Drug Administration (FDA) today approved an oral form of androgen deprivation therapy (ADT) known as relugolix (Orgovyx) for the treatment of...

Genetic Differences by Ancestry and Prostate Cancer Therapies

There are genetic differences when comparing prostate tumors from African American men and European-American men, but none of these differences are of clinical significance for...

FDA Approves Olaparib for Certain Metastatic Prostate Cancers

The US Food and Drug Administration approved olaparib (Lynparza, AstraZeneca) for deleterious or suspected deleterious germline or somatic homologous recombination repair (HRR) gene-mutated metastatic castration-resistant...

EU Panel OKs Glasdegib for AML & Luspatercept for MDS

A new drug for acute myeloid leukemia (AML), glasdegib (Daurismo, Pfizer). is approaching approval in Europe. The drug was approved in the United States in...

‘Bold’ Prostate Cancer Trial Enrolls ‘Very, Very Quickly’

Once the stuff of headlines and clinical buzz, sipuleucel-T (Provenge, Dendreon) has had a steep decline in its profile as a prostate cancer treatment. But...